How to Register a Medical Device in Colombia: A Step-by-Step Guide

how-to-register-a-medical-device-in-colombia-a-step-by-step-guide

Introduction

Navigating the complex landscape of medical device registration in Colombia presents significant challenges for manufacturers eager to enter this dynamic market. With INVIMA, the National Institute for Food and Drug Surveillance, leading the way, grasping the regulatory framework is essential for ensuring compliance and achieving successful market entry. This guide outlines the critical steps in the registration process, highlights the necessary documentation, and emphasizes the importance of post-approval compliance. As the stakes for medical devices rise concerning safety and efficacy, manufacturers must consider:

  • How can they effectively streamline their registration efforts while adhering to INVIMA’s stringent guidelines?

Understand INVIMA’s Role in Medical Device Registration

The National Institute for Food and Drug Surveillance is the that provides guidance on how to and approve . Its pivotal role in ensuring that is essential for successful market entry. The regulatory agency meticulously assesses technical documentation, clinical information, and adherence to local regulations, guaranteeing that only products meeting these criteria are marketed in Colombia.

Understanding the of the regulatory agency is vital, as it organizes products into four risk categories: Class I, Class IIa, Class IIb, and Class III. This classification directly influences the registration requirements; for instance, , while , including an extensive review of clinical data and technical specifications.

Recent updates from INVIMA underscore its commitment to enhancing the regulatory framework, which has been instrumental in fostering a safer environment. The agency’s rigorous procedures not only protect patients but also bolster consumer trust in medical technologies.

Additionally, the presence of and the COFEPRIS 30-day approval pathway streamline the process for . Case studies illustrate the organization’s impact: for example, the swift endorsement of innovative products has been linked to , particularly in high-demand areas like cardiology and diagnostics. By familiarizing yourself with the organization’s processes and requirements, including how to and the necessity of obtaining a for importers, you can navigate the registration landscape more effectively, ensuring compliance and expediting your product’s entry into the Colombian market.

The central node represents INVIMA's role, while branches show different aspects of the registration process. Each classification category highlights the varying levels of regulatory scrutiny, helping you understand how to navigate the registration landscape.

Gather Required Documentation for Registration

To understand with INVIMA, it’s crucial to compile a comprehensive set of documentation that meets regulatory standards. This process not only ensures compliance but also shows you , thereby accelerating your route to market. The required documents typically include:

  1. Instrument Description: A thorough description of the medical instrument, detailing its intended use and classification.
  2. : This includes design specifications, manufacturing methods, and quality management system (QMS) documentation. While is prevalent among manufacturers, alternatives such as ISO 9001 or an FDA Establishment Report may also be acceptable.
  3. Clinical Data: Depending on the classification of the equipment, you may need to provide or evidence demonstrating safety and efficacy. This data is essential, as it supports the and ensures adherence to INVIMA’s standards.
  4. : This document certifies that the product is legally marketed in the manufacturer’s home country, facilitating the registration process in Colombia.
  5. : If you lack a local presence in Colombia, appointing a legal representative is mandatory. Documentation of their authorization must be included in your submission.
  6. : A comprehensive risk analysis identifying potential hazards associated with the device and outlining mitigation strategies is essential for demonstrating safety.
  7. : All labels and instructions for use must be provided in Spanish and comply with the local labeling requirements.

By carefully organizing these documents, you can simplify the procedure with the regulatory body, which is crucial for understanding , ensuring adherence and accelerating your route to market.

The central node represents the main topic of documentation needed for registration. Each branch shows a specific document required, with descriptions that explain why each is important for the registration process.

Once you’ve gathered all the necessary documentation, it’s time to navigate the . Here’s how to proceed:

  1. Submit Application: Use the electronic platform to submit your registration application along with all supporting documentation. Don’t forget to pay any applicable fees during this step, which typically range from USD 750 for Class I and IIa items to USD 850 for Class IIb and III items.
  2. Initial Review: The regulatory body will conduct an initial review to ensure all required documents are submitted. If any documents are missing or incomplete, they will notify you for corrections. This step is crucial for maintaining compliance.
  3. : After the initial review, your application will undergo a . This procedure assesses the safety and effectiveness of the equipment based on the submitted information, ensuring your product meets regulatory standards.
  4. Approval or Rejection: If your apparatus meets all regulatory requirements, INVIMA will issue a . If not, they will provide feedback on the reasons for rejection, allowing you to make necessary adjustments to your application.
  5. Timeline: The approval procedure can take anywhere from 2 to 8 months, depending on the classification of the item. of 2-4 days, while Class IIb and III devices may take 3-6 months. Recent changes in regulatory timelines for 2025 have simplified the approval procedure, decreasing review times by approximately 20%. Understanding these timelines is essential for .

By following these steps and maintaining transparent communication with the relevant authority, you can successfully navigate the and work towards acquiring your certification. Additionally, leveraging bioaccess’s expertise in , along with our swift patient recruitment capabilities, can facilitate prompt market access and enhance your . It is important to understand , as medical equipment registrations are valid for 10 years, and Class I and IIa submissions can be accepted immediately, allowing manufacturers to start importing right away.

Each box represents a step in the approval journey. Follow the arrows to see how each step leads to the next, from submitting your application to receiving approval or feedback.

Ensure Post-Approval Compliance and Reporting

After successfully registering your medical product with the regulatory agency, maintaining ongoing compliance and timely reporting is essential. Here are the key responsibilities:

  • : Continuous monitoring of your product’s performance in the market is critical. You must or product defects to the relevant authority within specified timelines. Notably, from 5,447 in 2013 to 95,658 in 2017, highlighting the importance of vigilant monitoring and compliance.
  • : Registration certificates are valid for ten years and must be renewed periodically. Furthermore, any alterations to the apparatus or its labeling, particularly those impacting safety or effectiveness, must be communicated to the regulatory authority at least 30 days prior to promoting the changes.
  • (PSURs): Depending on the categorization of your product, you may be required to submit PSURs. These reports outline the safety and efficacy information gathered during the product’s lifecycle, ensuring that the regulatory body is kept updated on any developments.
  • : It is essential to remain informed about any released by the authority, as these can greatly affect your product’s compliance status. Proactive engagement with regulatory updates can mitigate risks associated with non-compliance.
  • : Keeping all documentation related to the apparatus current, including technical files and clinical data, is vital for readiness during audits or inspections by INVIMA. A well-documented approach not only supports compliance but also enhances credibility with regulators.

By adhering to these , you can maintain your device’s market authorization and contribute to patient safety, ultimately fostering trust in your product and the healthcare system.

Each box represents a key responsibility for maintaining compliance after product approval. Follow the arrows to understand the sequence of actions required to ensure ongoing compliance and reporting.

Conclusion

Navigating the registration of medical devices in Colombia is not just a bureaucratic hurdle; it’s a critical process that demands a thorough understanding of INVIMA regulations and procedures. This guide has illuminated the essential steps involved, from gathering necessary documentation to ensuring ongoing compliance post-approval. Adhering to these regulatory standards is vital for successful market entry and ultimately fosters trust in medical technologies.

Key points highlighted include the pivotal role of INVIMA in safeguarding public health through rigorous evaluation processes. The classification system dictates registration requirements, and specific documentation is crucial for a smooth application. Additionally, understanding the approval timeline and post-market responsibilities underscores the ongoing commitment manufacturers must uphold to maintain compliance and ensure patient safety.

In conclusion, grasping how to register a medical device in Colombia enhances patient outcomes and contributes to a safer healthcare environment. Manufacturers are encouraged to stay informed about regulatory updates and actively engage with INVIMA. This proactive approach not only streamlines their product’s journey to market but also reinforces their commitment to public health.

Frequently Asked Questions

What is INVIMA and what is its role in medical device registration in Colombia?

INVIMA, the National Institute for Food and Drug Surveillance, is the regulatory authority in Colombia responsible for guiding the registration and approval of medical devices to ensure they meet safety and efficacy standards.

How does INVIMA classify medical devices?

INVIMA classifies medical devices into four risk categories: Class I, Class IIa, Class IIb, and Class III. This classification affects the registration requirements, with Class I items facing fewer regulatory hurdles and Class III items undergoing thorough examinations.

What are the implications of the classification system on registration requirements?

The classification system directly influences the registration process; Class I devices have simpler requirements, while Class III devices require extensive reviews of clinical data and technical specifications.

What recent updates have been made by INVIMA?

Recent updates from INVIMA focus on enhancing the regulatory framework, which aims to foster a safer environment for medical equipment and improve consumer trust in medical technologies.

How do accredited hospitals and the COFEPRIS approval pathway impact the registration process?

The presence of ICH GCP accredited hospitals in Colombia and the COFEPRIS 30-day approval pathway help streamline the process for medical equipment registration, facilitating quicker market entry.

Can you provide an example of INVIMA’s impact on medical device registration?

Case studies show that INVIMA’s swift endorsement of innovative products has led to improved patient outcomes, particularly in high-demand areas like cardiology and diagnostics.

What is the Certificate of Storage and Conditioning Capacity (CCAA) and why is it necessary?

The Certificate of Storage and Conditioning Capacity (CCAA) is required for importers of medical devices in Colombia, ensuring compliance with local regulations and facilitating the registration process.

List of Sources

  1. Understand INVIMA’s Role in Medical Device Registration
    • emergobyul.com (https://emergobyul.com/services/invima-medical-device-registration-and-approval-colombia)
    • artixio.com (https://artixio.com/post/medical-device-regulations-in-colombia-a-comprehensive-guide)
    • statista.com (https://statista.com/outlook/hmo/medical-technology/medical-devices/colombia?srsltid=AfmBOoqD06UYegYl-I8Vf3hGZhh0-5thDk0xkrbfSriny1hpNs4nFOwZ)
    • trade.gov (https://trade.gov/knowledge-product/colombia-medical-equipment)
    • fortunebusinessinsights.com (https://fortunebusinessinsights.com/colombia-medical-devices-market-107897)
  2. Gather Required Documentation for Registration
    • emergobyul.com (https://emergobyul.com/services/invima-medical-device-registration-and-approval-colombia)
    • pureglobal.com (https://pureglobal.com/markets/colombia/invima-medical-device-regulations)
    • pureglobal.com (https://pureglobal.com/markets/colombia)
    • regdesk.co (https://regdesk.co/blog/the-lowdown-on-medical-device-regulations-in-colombia)
  3. Navigate the INVIMA Approval Process
    • arazygroup.com (https://arazygroup.com/ivd-medical-device-registration-colombia)
    • emergobyul.com (https://emergobyul.com/services/invima-medical-device-registration-and-approval-colombia)
    • bioaccessla.com (https://bioaccessla.com/blog/navigating-invima-requirements-for-medical-devices-a-step-by-step-guide)
    • pureglobal.com (https://pureglobal.com/blog-posts/medical-device-registration-costs-and-timelines-for-brazil-mexico-and-colombia)
  4. Ensure Post-Approval Compliance and Reporting
    • bioaccessla.com (https://bioaccessla.com/blog/10-key-insights-on-post-market-surveillance-for-medical-devices)
    • ramos-starnesprojects.com (https://ramos-starnesprojects.com/post/colombia-medical-device-reporting-requirements)
    • pubmed.ncbi.nlm.nih.gov (https://pubmed.ncbi.nlm.nih.gov/30411692)
    • arbormetrix.com (https://arbormetrix.com/blog/post-market-surveillance)
    • bioaccessla.com (https://bioaccessla.com/blog/navigating-invima-requirements-for-medical-devices-a-step-by-step-guide)

{“@context”: “https://schema.org”, “@type”: “FAQPage”, “mainEntity”: [{“@type”: “Question”, “name”: “What is INVIMA and what is its role in medical device registration in Colombia?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “INVIMA, the National Institute for Food and Drug Surveillance, is the regulatory authority in Colombia responsible for guiding the registration and approval of medical devices to ensure they meet safety and efficacy standards.”}}, {“@type”: “Question”, “name”: “How does INVIMA classify medical devices?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “INVIMA classifies medical devices into four risk categories: Class I, Class IIa, Class IIb, and Class III. This classification affects the registration requirements, with Class I items facing fewer regulatory hurdles and Class III items undergoing thorough examinations.”}}, {“@type”: “Question”, “name”: “What are the implications of the classification system on registration requirements?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “The classification system directly influences the registration process; Class I devices have simpler requirements, while Class III devices require extensive reviews of clinical data and technical specifications.”}}, {“@type”: “Question”, “name”: “What recent updates have been made by INVIMA?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Recent updates from INVIMA focus on enhancing the regulatory framework, which aims to foster a safer environment for medical equipment and improve consumer trust in medical technologies.”}}, {“@type”: “Question”, “name”: “How do accredited hospitals and the COFEPRIS approval pathway impact the registration process?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “The presence of ICH GCP accredited hospitals in Colombia and the COFEPRIS 30-day approval pathway help streamline the process for medical equipment registration, facilitating quicker market entry.”}}, {“@type”: “Question”, “name”: “Can you provide an example of INVIMA’s impact on medical device registration?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Case studies show that INVIMA’s swift endorsement of innovative products has led to improved patient outcomes, particularly in high-demand areas like cardiology and diagnostics.”}}, {“@type”: “Question”, “name”: “What is the Certificate of Storage and Conditioning Capacity (CCAA) and why is it necessary?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “The Certificate of Storage and Conditioning Capacity (CCAA) is required for importers of medical devices in Colombia, ensuring compliance with local regulations and facilitating the registration process.”}}]}{“@context”: “https://schema.org”, “@type”: “BlogPosting”, “headline”: “How to Register a Medical Device in Colombia: A Step-by-Step Guide”, “description”: “Learn how to register a medical device in Colombia with our comprehensive step-by-step guide.”, “datePublished”: “2026-03-04T00:58:58.472000”, “dateModified”: “2026-06-21T02:34:42.322410+00:00”, “articleBody”: “## Introduction\nNavigating the complex landscape of medical device registration in Colombia presents significant challenges for manufacturers eager to enter this dynamic market. With INVIMA, the National Institute for Food and Drug Surveillance, leading the way, grasping the regulatory framework is essential for ensuring compliance and achieving successful market entry. This guide outlines the critical steps in the registration process, highlights the necessary documentation, and emphasizes the importance of post-approval compliance. As the stakes for medical devices rise concerning safety and efficacy, manufacturers must consider:\n\n- How can they effectively streamline their registration efforts while adhering to INVIMA’s stringent guidelines?\n\n## Understand INVIMA’s Role in Medical Device Registration\n\nThe National Institute for Food and Drug Surveillance is the that provides guidance on how to and approve . Its pivotal role in ensuring that is essential for successful market entry. The regulatory agency meticulously assesses technical documentation, clinical information, and adherence to local regulations, guaranteeing that only products meeting these criteria are marketed in Colombia.\n\nUnderstanding the of the regulatory agency is vital, as it organizes products into four risk categories: Class I, Class IIa, Class IIb, and Class III. This classification directly influences the registration requirements; for instance, , while , including an extensive review of clinical data and technical specifications.\n\nRecent updates from INVIMA underscore its commitment to enhancing the regulatory framework, which has been instrumental in fostering a safer environment. The agency’s rigorous procedures not only protect patients but also bolster consumer trust in medical technologies.\n\nAdditionally, the presence of and the COFEPRIS 30-day approval pathway streamline the process for . Case studies illustrate the organization’s impact: for example, the swift endorsement of innovative products has been linked to , particularly in high-demand areas like cardiology and diagnostics. By familiarizing yourself with the organization’s processes and requirements, including how to and the necessity of obtaining a for importers, you can navigate the registration landscape more effectively, ensuring compliance and expediting your product’s entry into the Colombian market.\n\n![The central node represents INVIMA’s role, while branches show different aspects of the registration process. Each classification category highlights the varying levels of regulatory scrutiny, helping you understand how to navigate the registration landscape.](https://images.tely.ai/telyai/okaqvywg-the-central-node-represents-invim-as-role-while-branches-show-different-aspects-of-the-registration-process-each-classification-category-highlights-the-varying-levels-of-regulatory-scrutiny-helping-you-understand-how-to-navigate-the-registration-landscape.webp \”The central node represents INVIMA’s role, while branches show different aspects of the registration process. Each classification category highlights the varying levels of regulatory scrutiny, helping you understand how to navigate the registration landscape.\”)\n\n## Gather Required Documentation for Registration\n\nTo understand with INVIMA, it’s crucial to compile a comprehensive set of documentation that meets regulatory standards. This process not only ensures compliance but also shows you , thereby accelerating your route to market. The required documents typically include:\n\n1. Instrument Description: A thorough description of the medical instrument, detailing its intended use and classification.\n2. : This includes design specifications, manufacturing methods, and quality management system (QMS) documentation. While is prevalent among manufacturers, alternatives such as ISO 9001 or an FDA Establishment Report may also be acceptable.\n3. Clinical Data: Depending on the classification of the equipment, you may need to provide or evidence demonstrating safety and efficacy. This data is essential, as it supports the and ensures adherence to INVIMA’s standards.\n4. : This document certifies that the product is legally marketed in the manufacturer’s home country, facilitating the registration process in Colombia.\n5. : If you lack a local presence in Colombia, appointing a legal representative is mandatory. Documentation of their authorization must be included in your submission.\n6. : A comprehensive risk analysis identifying potential hazards associated with the device and outlining mitigation strategies is essential for demonstrating safety.\n7. : All labels and instructions for use must be provided in Spanish and comply with the local labeling requirements.\n\nBy carefully organizing these documents, you can simplify the procedure with the regulatory body, which is crucial for understanding , ensuring adherence and accelerating your route to market.\n\n![The central node represents the main topic of documentation needed for registration. Each branch shows a specific document required, with descriptions that explain why each is important for the registration process.](https://images.tely.ai/telyai/cbdkokiw-the-central-node-represents-the-main-topic-of-documentation-needed-for-registration-each-branch-shows-a-specific-document-required-with-descriptions-that-explain-why-each-is-important-for-the-registration-process.webp \”The central node represents the main topic of documentation needed for registration. Each branch shows a specific document required, with descriptions that explain why each is important for the registration process.\”)\n\n## Navigate the INVIMA Approval Process\n\nOnce you’ve gathered all the necessary documentation, it’s time to navigate the . Here’s how to proceed:\n\n1. Submit Application: Use the electronic platform to submit your registration application along with all supporting documentation. Don’t forget to pay any applicable fees during this step, which typically range from USD 750 for Class I and IIa items to USD 850 for Class IIb and III items.\n2. Initial Review: The regulatory body will conduct an initial review to ensure all required documents are submitted. If any documents are missing or incomplete, they will notify you for corrections. This step is crucial for maintaining compliance.\n3. : After the initial review, your application will undergo a . This procedure assesses the safety and effectiveness of the equipment based on the submitted information, ensuring your product meets regulatory standards.\n4. Approval or Rejection: If your apparatus meets all regulatory requirements, INVIMA will issue a . If not, they will provide feedback on the reasons for rejection, allowing you to make necessary adjustments to your application.\n5. Timeline: The approval procedure can take anywhere from 2 to 8 months, depending on the classification of the item. of 2-4 days, while Class IIb and III devices may take 3-6 months. Recent changes in regulatory timelines for 2025 have simplified the approval procedure, decreasing review times by approximately 20%. Understanding these timelines is essential for .\n\nBy following these steps and maintaining transparent communication with the relevant authority, you can successfully navigate the and work towards acquiring your certification. Additionally, leveraging bioaccess’s expertise in , along with our swift patient recruitment capabilities, can facilitate prompt market access and enhance your . It is important to understand , as medical equipment registrations are valid for 10 years, and Class I and IIa submissions can be accepted immediately, allowing manufacturers to start importing right away.\n\n![Each box represents a step in the approval journey. Follow the arrows to see how each step leads to the next, from submitting your application to receiving approval or feedback.](https://images.tely.ai/telyai/yjkjkage-each-box-represents-a-step-in-the-approval-journey-follow-the-arrows-to-see-how-each-step-leads-to-the-next-from-submitting-your-application-to-receiving-approval-or-feedback.webp \”Each box represents a step in the approval journey. Follow the arrows to see how each step leads to the next, from submitting your application to receiving approval or feedback.\”)\n\n## Ensure Post-Approval Compliance and Reporting\n\nAfter successfully registering your medical product with the regulatory agency, maintaining ongoing compliance and timely reporting is essential. Here are the key responsibilities:\n\n- : Continuous monitoring of your product’s performance in the market is critical. You must or product defects to the relevant authority within specified timelines. Notably, from 5,447 in 2013 to 95,658 in 2017, highlighting the importance of vigilant monitoring and compliance.\n- : Registration certificates are valid for ten years and must be renewed periodically. Furthermore, any alterations to the apparatus or its labeling, particularly those impacting safety or effectiveness, must be communicated to the regulatory authority at least 30 days prior to promoting the changes.\n- (PSURs): Depending on the categorization of your product, you may be required to submit PSURs. These reports outline the safety and efficacy information gathered during the product’s lifecycle, ensuring that the regulatory body is kept updated on any developments.\n- : It is essential to remain informed about any released by the authority, as these can greatly affect your product’s compliance status. Proactive engagement with regulatory updates can mitigate risks associated with non-compliance.\n- : Keeping all documentation related to the apparatus current, including technical files and clinical data, is vital for readiness during audits or inspections by INVIMA. A well-documented approach not only supports compliance but also enhances credibility with regulators.\n\nBy adhering to these , you can maintain your device’s market authorization and contribute to patient safety, ultimately fostering trust in your product and the healthcare system.\n\n![Each box represents a key responsibility for maintaining compliance after product approval. Follow the arrows to understand the sequence of actions required to ensure ongoing compliance and reporting.](https://images.tely.ai/telyai/efanwwfk-each-box-represents-a-key-responsibility-for-maintaining-compliance-after-product-approval-follow-the-arrows-to-understand-the-sequence-of-actions-required-to-ensure-ongoing-compliance-and-reporting.webp \”Each box represents a key responsibility for maintaining compliance after product approval. Follow the arrows to understand the sequence of actions required to ensure ongoing compliance and reporting.\”)\n\n## Conclusion\nNavigating the registration of medical devices in Colombia is not just a bureaucratic hurdle; it’s a critical process that demands a thorough understanding of INVIMA regulations and procedures. This guide has illuminated the essential steps involved, from gathering necessary documentation to ensuring ongoing compliance post-approval. Adhering to these regulatory standards is vital for successful market entry and ultimately fosters trust in medical technologies.\n\nKey points highlighted include the pivotal role of INVIMA in safeguarding public health through rigorous evaluation processes. The classification system dictates registration requirements, and specific documentation is crucial for a smooth application. Additionally, understanding the approval timeline and post-market responsibilities underscores the ongoing commitment manufacturers must uphold to maintain compliance and ensure patient safety.\n\nIn conclusion, grasping how to register a medical device in Colombia enhances patient outcomes and contributes to a safer healthcare environment. Manufacturers are encouraged to stay informed about regulatory updates and actively engage with INVIMA. This proactive approach not only streamlines their product’s journey to market but also reinforces their commitment to public health.\n\n::iframe[https://iframe.tely.ai/cta/eyJhcnRpY2xlX2lkIjogIjY5YTc4M2QyZjU2M2E4ZjgxOTYyMzMxOCIsICJjb21wYW55X2lkIjogIjY2OTk4NmYwMzM1YWQwNDI3ZTVmNTdlMyIsICJpbmRleCI6IG51bGwsICJ0eXBlIjogImFydGljbGUifQ==]{width=\”100%\” height=\”300px\”}”, “image”: [“https://images.tely.ai/telyai/okaqvywg-the-central-node-represents-invim-as-role-while-branches-show-different-aspects-of-the-registration-process-each-classification-category-highlights-the-varying-levels-of-regulatory-scrutiny-helping-you-understand-how-to-navigate-the-registration-landscape.webp”, “https://images.tely.ai/telyai/cbdkokiw-the-central-node-represents-the-main-topic-of-documentation-needed-for-registration-each-branch-shows-a-specific-document-required-with-descriptions-that-explain-why-each-is-important-for-the-registration-process.webp”, “https://images.tely.ai/telyai/yjkjkage-each-box-represents-a-step-in-the-approval-journey-follow-the-arrows-to-see-how-each-step-leads-to-the-next-from-submitting-your-application-to-receiving-approval-or-feedback.webp”, “https://images.tely.ai/telyai/efanwwfk-each-box-represents-a-key-responsibility-for-maintaining-compliance-after-product-approval-follow-the-arrows-to-understand-the-sequence-of-actions-required-to-ensure-ongoing-compliance-and-reporting.webp”], “inLanguage”: “en”, “author”: {“@type”: “Organization”, “name”: “bioaccess®”}, “publisher”: {“@type”: “Organization”, “name”: “bioaccess®”, “url”: “https://bioaccessla.com”}}

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *